http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030051858-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate | 2001-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20030051858-A |
| titleOfInvention | Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation |
| abstract | The present invention relates to the field of therapeutic chemistry and more particularly to the manufacture of novel pharmaceuticals for the treatment of diabetes. In particular, the present invention relates to two activities that are effective via oral route of administration at a reverse dose, formed from antidiabetic biguanides and antidiabetic sulfonamides, together with or as one or more inert, pharmaceutically acceptable excipients. A novel antidiabetic drug consisting of a combination of ingredients. The invention also relates to a process for the preparation of such a medicament formed from biguanides and sulfonamides. |
| priorityDate | 2000-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 220.